# Arcturus Therapeutics Holdings Inc.: Form 8-K, filed Nov 1, 2021

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: 8-K
- Filed: 2021-11-01
- Accepted by EDGAR: Nov 1, 2021, 16:30 ET
- Period: 2021-10-27
- Accession: 0001193805-21-001517
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380521001517/e621046_8k-at.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380521001517/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380521001517/e621046_8k-at.htm

Filed Nov 1, 2021.
Source: SEC EDGAR, the filing index for accession 0001193805-21-001517. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
